Chronic endothelial damage could underlie the systemic inflammation in LC, characterized by elevated levels of proinflammatory markers such as interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor alpha (TNFα) (16, 17). The gene discussed is IL6; the disease is laryngotracheoesophageal cleft.